254 related articles for article (PubMed ID: 15450333)
1. From laboratory to clinic: rationale for biologic therapy.
Mehlis S; Gordon KB
Dermatol Clin; 2004 Oct; 22(4):371-7, vii-viii. PubMed ID: 15450333
[TBL] [Abstract][Full Text] [Related]
2. Review of therapy of psoriasis: the prebiologic armamentarium.
Aaronson DS; Lebwohl M
Dermatol Clin; 2004 Oct; 22(4):379-88, viii. PubMed ID: 15450334
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
Alwawi EA; Krulig E; Gordon KB
Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences.
Kormeili T; Lowe NJ; Yamauchi PS
Br J Dermatol; 2004 Jul; 151(1):3-15. PubMed ID: 15270867
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
6. Practical considerations in future psoriasis therapies.
Riddle C; Young M; Menter A
Dermatol Clin; 2004 Oct; 22(4):487-92, x. PubMed ID: 15450344
[TBL] [Abstract][Full Text] [Related]
7. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
[TBL] [Abstract][Full Text] [Related]
8. Retinoid therapy for psoriasis.
Yamauchi PS; Rizk D; Lowe NJ
Dermatol Clin; 2004 Oct; 22(4):467-76, x. PubMed ID: 15450342
[TBL] [Abstract][Full Text] [Related]
9. The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety.
Yamauchi PS; Gindi V; Lowe NJ
Dermatol Clin; 2004 Oct; 22(4):449-59, ix. PubMed ID: 15450340
[TBL] [Abstract][Full Text] [Related]
10. Phototherapy arsenal in the treatment of psoriasis.
Zanolli M
Dermatol Clin; 2004 Oct; 22(4):397-406, viii. PubMed ID: 15450336
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.
Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM
J Dermatolog Treat; 2009; 20(1):42-7. PubMed ID: 18649164
[TBL] [Abstract][Full Text] [Related]
12. Biological therapies in the systemic management of psoriasis: International Consensus Conference.
Sterry W; Barker J; Boehncke WH; Bos JD; Chimenti S; Christophers E; De La Brassinne M; Ferrandiz C; Griffiths C; Katsambas A; Kragballe K; Lynde C; Menter A; Ortonne JP; Papp K; Prinz J; Rzany B; Ronnevig J; Saurat JH; Stahle M; Stengel FM; Van De Kerkhof P; Voorhees J
Br J Dermatol; 2004 Aug; 151 Suppl 69():3-17. PubMed ID: 15265063
[TBL] [Abstract][Full Text] [Related]
13. Combining traditional systemic and biologic therapies for psoriasis.
Heffernan MP
Semin Cutan Med Surg; 2010 Mar; 29(1):67-9. PubMed ID: 20430311
[TBL] [Abstract][Full Text] [Related]
14. Evolution of biologic therapies for the treatment of psoriasis.
Gordon KB; McCormick TS
Skinmed; 2003; 2(5):286-94. PubMed ID: 14673261
[TBL] [Abstract][Full Text] [Related]
15. [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology].
Puig L; Bordas X; Carrascosa JM; Daudén E; Ferrándiz C; Hernanz JM; López-Estebaranz JL; Moreno JC; Sánchez-Carazo JL; Vanaclocha F; Vázquez-Veiga H;
Actas Dermosifiliogr; 2009 May; 100(4):277-86. PubMed ID: 19463230
[TBL] [Abstract][Full Text] [Related]
16. Contemporary management of moderate to severe plaque psoriasis.
Wu JJ
Am J Manag Care; 2017 Dec; 23(21 Suppl):S403-S416. PubMed ID: 29297664
[TBL] [Abstract][Full Text] [Related]
17. A clinician's paradigm in the treatment of psoriasis.
Lebwohl M
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S59-69. PubMed ID: 15968265
[TBL] [Abstract][Full Text] [Related]
18. Biologics in combination with nonbiologics: efficacy and safety.
Stebbins WG; Lebwohl MG
Dermatol Ther; 2004; 17(5):432-40. PubMed ID: 15379778
[TBL] [Abstract][Full Text] [Related]
19. Disease and treatment burden of psoriasis: examining the impact of biologics.
Raval K; Lofland JH; Waters H; Piech CT
J Drugs Dermatol; 2011 Feb; 10(2):189-96. PubMed ID: 21283925
[TBL] [Abstract][Full Text] [Related]
20. Novel pharmacological approaches in the treatment of psoriasis.
Schleyer V; Landthaler M; Szeimies RM
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):1-20. PubMed ID: 15649186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
